Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S de Bono

Showing results (121-130 of 492) with videos related to

Pageof 50
Sort By:
Cancer|September 21, 2016
Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trialYohann Loriot, Karim Fizazi, Johann S de Bono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2011
Reporting the capture efficiency of a filter-based microdevice: a CTC is not a CTC unless it is CD45 negative--letterGerhardt Attard, Mateus Crespo, Ai Chiin Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear BenefitsRavi A Madan, Fatima Karzai, David J VanderWeele, et al.
Prostate Cancer and Prostatic Diseases|September 28, 2016
Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancerG Sonpavde, G R Pond, A J Templeton, et al.
Cancer Treatment and Research Communications|January 31, 2021
AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualificationAdam G Sowalsky, Adam Sharp, Shana Y Trostel, et al.
Nature Reviews. Clinical Oncology|October 17, 2013
Appraising iniparib, the PARP inhibitor that never was--what must we learn?Joaquin Mateo, Michael Ong, David S P Tan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 28, 2018
Health economic impact of liquid biopsies in cancer managementMaarten J IJzerman, A M Sofie Berghuis, Johann S de Bono, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 11, 2014
Therapy monitoring of skeletal metastases with whole-body diffusion MRIAnwar R Padhani, Andreas Makris, Peter Gall, et al.
Journal of Musculoskeletal & Neuronal Interactions|April 10, 2008
Could image analysis of pQCT scans provide additional information about bone strength?S de Bono, M A Laskey, C N Shaw, et al.
Bone Marrow Transplantation|February 21, 2012
The psychosocial impact of haematopoietic SCT on sibling donorsB Pillay, S J Lee, L Katona, et al.
Pageof 50

Showing results (121-130 of 492) with videos related to

Sort By:
Pageof 50
Cancer|September 21, 2016
Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trialYohann Loriot, Karim Fizazi, Johann S de Bono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2011
Reporting the capture efficiency of a filter-based microdevice: a CTC is not a CTC unless it is CD45 negative--letterGerhardt Attard, Mateus Crespo, Ai Chiin Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear BenefitsRavi A Madan, Fatima Karzai, David J VanderWeele, et al.
Prostate Cancer and Prostatic Diseases|September 28, 2016
Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancerG Sonpavde, G R Pond, A J Templeton, et al.
Cancer Treatment and Research Communications|January 31, 2021
AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualificationAdam G Sowalsky, Adam Sharp, Shana Y Trostel, et al.
Nature Reviews. Clinical Oncology|October 17, 2013
Appraising iniparib, the PARP inhibitor that never was--what must we learn?Joaquin Mateo, Michael Ong, David S P Tan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 28, 2018
Health economic impact of liquid biopsies in cancer managementMaarten J IJzerman, A M Sofie Berghuis, Johann S de Bono, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 11, 2014
Therapy monitoring of skeletal metastases with whole-body diffusion MRIAnwar R Padhani, Andreas Makris, Peter Gall, et al.
Journal of Musculoskeletal & Neuronal Interactions|April 10, 2008
Could image analysis of pQCT scans provide additional information about bone strength?S de Bono, M A Laskey, C N Shaw, et al.
Bone Marrow Transplantation|February 21, 2012
The psychosocial impact of haematopoietic SCT on sibling donorsB Pillay, S J Lee, L Katona, et al.
Pageof 50